Estrogen biosynthesis in endometriosis: Molecular basis and clinical relevance

S. E. Bulun, K. M. Zeitoun, K. Takayama, H. Sasano

Research output: Contribution to journalReview articlepeer-review

139 Citations (Scopus)

Abstract

Conversion of C(19) steroids to estrogens is catalyzed by aromatase in human ovary, placenta and extraglandular tissues such as adipose tissue, skin and the brain. Aromatase activity is not detectable in normal endometrium. In contrast, aromatase is expressed aberrantly in endometriosis and is stimulated by prostaglandin E2 (PGE2). This results in local production of estrogen, which induces PGE2 formation and establishes a positive feedback cycle. Another abnormality in endometriosis, i.e. deficient hydroxysteroid dehydrogenase (17β-HSD) type 2 expression, impairs the inactivation of estradiol to estrone. These molecular aberrations collectively favor accumulation of increasing quantities of estradiol and PGE2 in endometriosis. The clinical relevance of these findings was exemplified by the successful treatment of an unusually aggressive case of postmenopausal endometriosis using an aromatase inhibitor.

Original languageEnglish
Pages (from-to)35-42
Number of pages8
JournalJournal of Molecular Endocrinology
Volume25
Issue number1
DOIs
Publication statusPublished - 2000
Externally publishedYes

ASJC Scopus subject areas

  • Molecular Biology
  • Endocrinology

Fingerprint Dive into the research topics of 'Estrogen biosynthesis in endometriosis: Molecular basis and clinical relevance'. Together they form a unique fingerprint.

Cite this